Health Care & Life Sciences » Biotechnology | InVivo Therapeutics Holdings Corp.

InVivo Therapeutics Holdings Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
14,581.80
13,881.00
20,555.00
33,402.00
13,271.00
16,664
Other Current Assets
20.10
1,072.00
184.00
451.00
535.00
461
Total Current Assets
14,601.90
14,953.00
20,739.00
33,853.00
13,806.00
17,125
Net Property, Plant & Equipment
2,337.20
1,605.00
938.00
510.00
157.00
100
Intangible Assets
131.10
114.00
96.00
78.00
61.00
44
Other Assets
26.20
21.00
19.00
343.00
21.00
998
Total Assets
17,096.40
16,693.00
21,792.00
34,784.00
14,045.00
18,377
ST Debt & Current Portion LT Debt
76.80
338.00
395.00
423.00
452.00
Accounts Payable
899.30
-
-
-
988.00
Other Current Liabilities
1,292.20
8,837.00
2,917.00
4,425.00
1,672.00
Total Current Liabilities
2,268.20
9,175.00
3,312.00
4,848.00
3,112.00
Long-Term Debt
1,938.50
1,600.00
1,275.00
852.00
400.00
Other Liabilities
-
-
276.00
135.00
423.00
Total Liabilities
4,206.70
10,775.00
4,863.00
5,835.00
3,935.00
Common Equity (Total)
12,889.70
5,918.00
16,929.00
28,949.00
10,110.00
Total Shareholders' Equity
12,889.70
5,918.00
16,929.00
28,949.00
10,110.00
Total Equity
12,889.70
5,918.00
16,929.00
28,949.00
10,110.00
Liabilities & Shareholders' Equity
17,096.40
16,693.00
21,792.00
34,784.00
14,045.00

About InVivo Therapeutics Holdings

View Profile
Address
One Kendall Square
Cambridge Massachusetts 02139
United States
Employees -
Website http://www.invivotherapeutics.com
Updated 07/08/2019
Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of SCIs. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. The company was founded by Joseph P.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.